MP-C

General Information


DRACP ID  DRACP00816

Peptide Name   MP-C

Sequence  LNLKALLAVAKKIL

Sequence Length  14

UniProt ID  Not available

PubChem CID  Not available

Origin  wasp venom

Type  Native peptide

Classification

  

Active ACP Membrane-targeted



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
NCI-H157 Lung squamous cell carcinoma Carcinoma IC50=13.57 μM MTT assay 24h 1
MDA-MB-435S Amelanotic melanoma Carcinoma IC50=27.70 μM MTT assay 24h 1
PC-3 Prostate carcinoma Carcinoma IC50=6.29 μM MTT assay 24h 1
U-251MG Astrocytoma Carcinoma IC50=36.65 μM MTT assay 24h 1
MCF-7 Invasive breast carcinoma of no special type Carcinoma IC50=25.27 μM MTT assay 24h 1

Hemolytic Activity  Horse erythrocytes: HC50=40.11 μM

Normal (non-cancerous) Cytotoxicity  HMEC-1: IC50=57.15 μM

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antitumor; Antimicrobial



Structure Information


PDB ID  Not available

Predicted Structure  DRACP00816

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C72H134N18O16

Absent amino acids  CDEFGHMPQRSTWY

Common amino acids  L

Mass  174006

Pl  11.1

Basic residues  3

Acidic residues  0

Hydrophobic residues  10

Net charge  3

Boman Index  1570

Hydrophobicity  127.86

Aliphatic Index  209.29

Half Life 
  Mammalian: 1.2 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  1

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 29904274

Title  Evaluation of the bioactivity of a mastoparan peptide from wasp venom and of its analogues designed through targeted engineering

Doi 10.7150/ijbs.23419

Year  2018

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.